Desensitization – Asian Pacific Journal of Allergy and Immunology

HOME
ABOUT
EDITORS
SUBMISSION
- Online Submission
- Author Instructions
ISSUE
PERMISSIONS
CONTACT
ADVERTISE

Desensitization

September 22, 2023

Antituberculosis drug-induced non-blistering systemicsevere reactions: A 10-year (2012-2022) literature review

Drug reaction with eosinophilia and systemic symptoms (DRESS) and drug-induced liver injury (DILI) can hamper therapeutic strategy, contribute to multiple drug resistance and serious public health burden.

allergological management, Antituberculosis drugs, Desensitization, drug reaction with eosinophilia and systemic symptoms, drug-induced hypersensitivity syndrome, Drug-Induced Liver Injury, re-challenge, systemic severe reactions, T-cell-mediated hypersensitivity

January 30, 2021

Successful treatment of neurocysticercosis with albendazole desensitization

Neurocysticercosis is a growing public health problem in the United States. Albendazole is a mainstay of medical therapy for neurocysticercosis, and here we present a case of hypersensitivity to albendazole leading to life-threatening disease progression.

Adverse drug reaction, Albendazole, Anti-parasite, Desensitization, Drug hypersensitivity, Neurocysticercosis, Orally

Key words

Adherence allergen Allergic rhinitis Allergy Anaphylaxis anxiety Asthma atopic dermatitis child Children Chlorhexidine chronic rhinosinusitis chronic spontaneous urticaria Chronic Urticaria COVID-19 cytokine depression drug allergy Drug hypersensitivity efficacy Epidemiology food allergy house dust mite hypersensitivity IgE Immunotherapy obstructive sleep apnea Omalizumab prevalence primary immunodeficiency Quality of life Questionnaire Reliability risk factor risk factors safety SARS-CoV-2 Sensitization Severe asthma Skin prick test Specific IgE Thai treatment urticaria vaccine

Support Contact

Managing Editor
Ms. Patrawadee Pitakpolrat
E-mail: managingeditor@apjai-journal.org

Production Editor
Ms. Chanita Jangsawang
E-mail: chanita.j@apjai-journal.org